American Alpha Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
American Alpha Advisors's PFE Position: Q3 2026 in Review
American Alpha Advisors increased its Pfizer (PFE) stake by 1.8% in Q3 2026, buying an estimated $10.7K and bringing the position to 22,393 shares worth $639K. The position accounts for 0.34% of the portfolio, ranked #49.
American Alpha Advisors first reported a position in PFE in Q1 2025 and has held it in 7 quarters since. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- American Alpha Advisors held 22,393 shares of Pfizer worth $639K as of Q3 2026.
- American Alpha Advisors bought 402 Pfizer shares in Q3 2026, an estimated $10.7K.
- Pfizer made up 0.34% of American Alpha Advisors's portfolio in Q3 2026, its #49 holding.
- American Alpha Advisors first reported a position in Pfizer in Q1 2025 and has held it in 7 quarters since.
- 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on American Alpha Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.